Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2010 1
2012 2
2013 2
2014 4
2015 2
2016 4
2018 1
2019 1
2020 4
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen.
Hagen P, D'Souza A, Hari P, Davila O, Zhang MJ, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ. Hagen P, et al. Among authors: rodriguez te. Leuk Lymphoma. 2020 Dec;61(14):3484-3492. doi: 10.1080/10428194.2020.1811275. Epub 2020 Aug 31. Leuk Lymphoma. 2020. PMID: 32865474 Free PMC article.
23 results